SCHEMBL1929645

SCHEMBL1929645

CCCNC(=O)c1cccc(C=Cc2ccccc2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.61
SMN1; SMN2 Q16637 2/20 0.56
ALDH1A1 P00352 3/20 0.56
POLB P06746 1/20 0.56
NAAA Q02083 1/20 0.51
ERN1 O75460 1/20 0.51
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
HDAC3 O15379 3/20 0.50
HDAC1 Q13547 3/20 0.50
HDAC4 P56524 2/20 0.50
HDAC7 Q8WUI4 2/20 0.50
HDAC2 Q92769 2/20 0.50
HDAC8 Q9BY41 2/20 0.50
HDAC6 Q9UBN7 2/20 0.50
HDAC9 Q9UKV0 2/20 0.50
HDAC5 Q9UQL6 2/20 0.50
KDM4E B2RXH2 1/20 0.50
GAA P10253 1/20 0.50
HPGD P15428 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1929644 1.00 L3MBTL1 (0.61) L3MBTL1SMN1; SMN2ALDH1A1POLBNAAA
SCHEMBL1927949 0.86 HDAC1 (0.62) L3MBTL1SMN1; SMN2ALDH1A1POLBNAAA
SCHEMBL1927947 0.86 HDAC1 (0.62) L3MBTL1SMN1; SMN2ALDH1A1POLBNAAA
SCHEMBL12644407 0.85 TTR (0.63) L3MBTL1SMN1; SMN2ALDH1A1POLBERN1
SCHEMBL13387633 0.85 TTR (0.63) L3MBTL1SMN1; SMN2ALDH1A1POLBERN1
SCHEMBL13763531 0.82 L3MBTL1 (0.80) L3MBTL1SMN1; SMN2ALDH1A1POLBNAAA
Benzene SCHEMBL28248159 0.81 NAAA (0.73) L3MBTL1SMN1; SMN2ALDH1A1POLBNAAA
SCHEMBL334957 0.81 NAAA (0.73) L3MBTL1SMN1; SMN2ALDH1A1POLBNAAA
SCHEMBL1927120 0.80 L3MBTL1 (0.67) L3MBTL1SMN1; SMN2ALDH1A1POLBNAAA
SCHEMBL6027923 0.80 L3MBTL1 (0.71) L3MBTL1SMN1; SMN2ALDH1A1POLBNAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1763509-B1 ALPHA-HELICAL MIMETICS WALTER & ELIZA HALL INST MEDICAL RES (AU) 2018-02-21 EP disclosed
US-7956216-B2 Benzoyl urea derivatives mimicing BH3-only proteins, able to interact with a Bcl-2 protein THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2011-06-07 US disclosed
US-20080153802-A1 Alpha-helical mimetics THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2008-06-26 US disclosed
EP-1763509-A1 ALPHA-HELICAL MIMETICS THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2007-03-21 EP disclosed
WO-2006002474-A1 ALPHA-HELICAL MIMETICS THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2006-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153802-A1 Alpha-helical mimetics BID, BAX, BAD L3MBTL1 85/4885SMN1; SMN2 860/4885ALDH1A1 4208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.